The antiphagocytic polysaccharide capsule of Streptococcus pneumoniae has long been been considered the principal virulence determinant of this organism. However, there is growing evidence that the toxin pneumolysin plays an important role in the pathogenesis of pneumococcal disease and may thus be a significant additional target for vaccine development.